Into the ordinary: non-elite actors and the mobility of harm reduction policies

Research on policy transfer and policy mobility has focused much attention on relatively elite actors, such as politicians, international organisations, think tanks, philanthropic donors, and consultancy firms. In contrast, this article uses the case of ‘harm reduction’ drug policy, an area of practice and research that is committed to valuing ‘non-elite’ actors, to show how they are frequently involved in mobilizing policy knowledge. Focusing...